Share on StockTwits

Dentsply International (NASDAQ:XRAY) Director Leslie A. Jones sold 2,000 shares of the company’s stock on the open market in a transaction dated Monday, August 25th. The stock was sold at an average price of $48.30, for a total transaction of $96,600.00. Following the sale, the director now directly owns 94,801 shares in the company, valued at approximately $4,578,888. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Dentsply International (NASDAQ:XRAY) traded down 0.69% during mid-day trading on Wednesday, hitting $48.06. 393,277 shares of the company’s stock traded hands. Dentsply International has a 52-week low of $41.57 and a 52-week high of $50.99. The stock has a 50-day moving average of $47.13 and a 200-day moving average of $46.48. The company has a market cap of $6.814 billion and a price-to-earnings ratio of 22.10.

Dentsply International (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, July 31st. The company reported $0.69 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.68 by $0.01. The company had revenue of $765.20 million for the quarter, compared to the consensus estimate of $782.86 million. During the same quarter last year, the company posted $0.66 earnings per share. Dentsply International’s revenue was up .6% compared to the same quarter last year. Analysts expect that Dentsply International will post $2.52 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Friday, October 10th. Stockholders of record on Friday, September 26th will be given a dividend of $0.0663 per share. This represents a $0.27 dividend on an annualized basis and a yield of 0.55%. The ex-dividend date of this dividend is Wednesday, September 24th.

Separately, analysts at Zacks reiterated a “neutral” rating on shares of Dentsply International in a research note on Friday, August 1st. They now have a $49.00 price target on the stock. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $51.00.

DENTSPLY International Inc (NASDAQ:XRAY) is a designer, developer, manufacturer and marketer of a range of dental products.

Receive News & Ratings for Dentsply International Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.